ANIZOME

Curated by Signal

Developer of an animal microbiome platform to develop therapeutics

Overview

Anizome has developed therapeutics to treat animal diseases. The company uses its microbiome platform technology to engineer microbiomes to target and treat diseases. The company is developing microbiome-based therapeutics to treat gastrointestinal, dermatology, and orthopedic diseases.

Key facts

Founded: 2018
Headquarters: Houston, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Medisoft247
Medical billing and electronic medical records software
Health TechnologyParamus, United States
CEHQ
Educational platform provider for nurses
Health TechnologyCedar Rapids, United States
FERMD
Provider of an online teleconsultation & appointment booking platform for multiple diseases
Health TechnologyMcallen, United States

About ANIZOME

What does ANIZOME do?

Anizome has developed therapeutics to treat animal diseases.

Where is ANIZOME headquartered?

ANIZOME is headquartered in Houston, United States.

When was ANIZOME founded?

ANIZOME was founded in 2018.

Which sector is ANIZOME in?

ANIZOME operates in Health Technology.

Who are ANIZOME's competitors?

Companies similar to ANIZOME include Medisoft247, CEHQ, and FERMD.